A price cap on insulin from one of the three major manufacturers took effect on New Year's Day, giving more Americans with diabetes more affordable treatments. As of Jan. 1, 2024, Sanofi cut the price ...

Insulin Analogues and Cancer Risk: Cause for Concern or Cause Célèbre? Are diabetes and diabetes treatments associated with an increased risk of cancer? How should the benefits of insulin therapy be ...

More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation’s two other major insulin manufacturers in offering either price caps or savings programs ...

Novo Nordisk will lower the U.S. list price of some of its insulin products by up to 75%, the Danish drugmaker said Tuesday. The change — which will take effect on Jan. 1, 2024 — follows a similar ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.

Should Insulin Therapy Be Adjusted for a Cardiac Stress Test? Several factors should be considered when a patient may require emergent surgery. Medscape Pharmacists, May 20, 2009 Tips for Initiating ...